In today’s briefing:
- Prodia Widya Husada (PRDA IJ) – Improving Diagnosis
Prodia Widya Husada (PRDA IJ) – Improving Diagnosis
- Prodia Widyahusada (PRDA IJ) is Indonesia’s reading diagnostic company, with around a 35% market share and a network of 392 outlets across the archipelago.
- PRDA booked +8.5% sales growth in 1H2026, with improving margins, as it shifted toward more esoteric testing. Testing volumes were driven by external referrals, doctors’ referrals, and corporate customers.
- The company’s digital sales through U by Prodia saw strong growth, with Prodia for Doctors also seeing increasing traction, but with lower capex. Valuations are attractive versus Indian comparables.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
